MedTrace Logo

Tamoxifen Pharmacogenetics and Clinical Effects

NCT00228930 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 297

Last updated 2008-09-25

No results posted yet for this study

Summary

The purpose of this research is to try to identify which women who take tamoxifen are likely to suffer from hot flashes or are more likely to have other side effects or benefits from the drug. The researchers will do so by determining whether there are mutations that normally occur in human DNA that might influence the way individuals respond to medications.

Conditions

Interventions

DRUG

Tamoxifen (pharmacodynamic analysis)

Tamoxifen 20mg po daily

Sponsors & Collaborators

  • Indiana University School of Medicine

    collaborator OTHER

  • National Institute of General Medical Sciences (NIGMS)

    lead NIH

Principal Investigators

  • David Flockhart, MD, PhD · Indiana University School of Medicine

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-09-30
Completion
2007-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00228930 on ClinicalTrials.gov